您当前的位置:
首页 >
文章列表页 >
MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies
RESEARCH | 更新时间:2025-12-13
    • MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies

    • MELK prevents radiofrequency ablation-induced immunogenic cell death and antitumor immune response by stabilizing FABP5 in hepatocellular malignancies

    • “在癌症治疗领域,研究人员取得了重大进展。他们发现射频消融(RFA)治疗上调了MELK的表达,MELK抑制通过免疫原性细胞死亡和抗肿瘤反应促进了RFA的疗效。通过RGD-LNPs靶向MELK为提高RFA在HCC临床治疗和对抗癌症恶性进展中的疗效提供了新的见解。”
    • Bu-Fu Tang ,Wang-Ting Xu ,Shi-Ji Fang ,Jin-Yu Zhu ,Rong-Fang Qiu ,Lin Shen ,Yang Yang ,Qiao-You Weng ,Ya-Jie Wang ,Jia-Yi Ding ,Xiao-Jie Zhang ,Wei-Qian Chen ,Li-Yun Zheng ,Jing-Jing Song ,Biao Chen ,Zhong-Wei Zhao ,Min-Jiang Chen ,Jian-Song Ji
    • MMR 2025年12卷第7期 页码:1046-1064
    • DOI: 10.1186/s40779-024-00588-7     

      中图分类号:

    移动端阅览

  •  
  •  
  • AI导读

  • HTML全文

  • 图( 8 ) 表( 0 )

  • 参考文献

  • 出版信息

  • 数据统计

48

浏览量

36

下载量

0

CSCD

文章被引用时,请邮件提醒。
提交
工具集
  • BibTeX下载
  • Endnote下载
  • RefMan 下载
  • NoteExpress下载
  • NoteFirst下载

相关文章

Immune microenvironment dynamics in pregnant patients with concomitant autoimmune diseases: mechanisms, challenges, and clinical significance
Role of the immune microenvironment in bone, cartilage, and soft tissue regeneration: from mechanism to therapeutic opportunity
mRNA vaccine development for cholangiocarcinoma: a precise pipeline
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patients
Maladaptive reorganization of mediodorsal thalamus as a central mechanism in neuropathic pain-related sleep disorders

相关作者

Ji-Xin Zhong
Xiao-Quan Rao
Ying-Ying Wei
Zachary Braunstein
Quan Gong
Shun-Ping Lin
Chen-Xi Yang
Jun Chen

相关机构

Key Laboratory of Vascular Aging (HUST), Ministry of Education
Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Division of Hematology, Department of Internal Medicine, James Comprehensive Cancer Center, the Ohio State University Wexner Medical Center
Department of Immunology, School of Medicine, Yangtze University
Fujian Institute of Clinical Immunology